A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Solution
NCT00389233 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 360
Last updated 2008-04-16
Summary
The study was carried out as a randomised, single-blind, active-controlled, multi-centric, phase III study with two parallel treatment groups. The primary efficacy criterion was the frequency of effective gut cleansing in each of the two treatment groups (grade A or B "overall quality of gut cleansing" as judged by a blinded expert panel on the basis of videotapes recorded during the endoscopic procedure).
Conditions
- Colonoscopy
Interventions
- DRUG
-
Macrogol3350 NA sulphate NACl KCl ascorbic acid NA ascorbate
1 pack will consist of 2L NRL 994 - 4 (2 x PEG + E/"P" + 2 x Vitamin C/"C") sachets for the 2L of 2 sachets (1 x "P" plus 1 x "C") will be dissolved in 1L of water. Each litre will be drunk within 1 hour followed by at least 500ml of any additional clear fluid.
- DRUG
-
Macrogol3350 Na sulphate Na bicarbonate NaCl KCl
1 pack will consist of 4L PEG + E - contains 4 sachets for the 4L of PEG + E/"P/E". Each sachet will be dissolved in 1L of water. Each litre will be drunk within 1 hour.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Christian Ell, Prof Dr med · Dept. of Internal Medicine II, Dr.-Horst-Schmidt Hospital, Teaching Hospital of the University Mainz
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-06-30
- Completion
- 2002-12-31
Countries
- Germany
Study Locations
More Related Trials
-
Study of NPF-08 in Patients Who Receive Colonoscopy
NCT03794310 ·Status: COMPLETED ·Phase: PHASE3
-
MoviPrep® Versus HalfLytely®, Low-VolUme PEG Solutions for Colon Cleansing: An InvesTigator-blindEd, Randomized, Trial
NCT00779649 ·Status: COMPLETED ·Phase: PHASE4
-
Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus MOVIPREP® Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults.
NCT02273167 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing the Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution With PREPOPIK® for Colon Cleansing in Preparation for Colonoscopy
NCT03017235 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Evaluation of a New Reduced Volume Bowel Preparation
NCT00321230 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Efficacy, Safety and Tolerance of Experimental Morning-only MOVIPREP® Bowel Preparation in Comparison With Split-dose With Nocturnal Pause MOVIPREP® Bowel Preparation
NCT01732692 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of mAnnitol in Bowel Preparation During Elective Colonoscopy and Comparison With Moviprep®
NCT04759885 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Multi-centre Study Comparing the Polyp Detection Rate of Two Different Types of Bowel Preparation: a 2-litre Solution (MOVIPREP®) Versus a Hyperosmotic and Stimulant Combined Low Volume Bowel Preparation (Sodium Picosulfate and Magnesium Citrate)
NCT01689792 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of an Edible Colonoscopy Preparation
NCT03332485 ·Status: COMPLETED ·Phase: PHASE2
-
Test of a New Gel-based Colon Cleansing Agent Compared to Moviprep
NCT03904303 ·Status: UNKNOWN ·Phase: PHASE1
-
A Trial Comparing the PICOPREP Tailored Dosing Schedule to the PICOPREP Day-before Dosing Schedule for Colon Cleansing in Preparation for Colonoscopy
NCT02239692 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective, Randomized, Single-blinded (Evaluator), Parallel, Multi-center, Phase 3 Trial in Bowel Preparation for Colonoscopy
NCT03544944 ·Status: COMPLETED ·Phase: PHASE3
-
2L Oral Bi-PegLyte Versus 2L Oral MoviPrep Regimen for Outpatient Colonic Preparation
NCT01865916 ·Status: COMPLETED ·Phase: PHASE4
-
Sodium Picosulphate/Magnesium Citrate and Low-volume PEG -Ascorbic Acid as Preparation for Colonoscopy
NCT01603654 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of 1 Liter PEG With Ascorbate and Sodium Picosulfate / Magnesium Citrate for High Quality Colon Cleansing
NCT04598880 ·Status: COMPLETED ·Phase: PHASE4
-
Multi-centre Failed Bowel Prep RCT
NCT02976805 ·Status: COMPLETED ·Phase: PHASE3
-
Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus a Sodium Picosulfate and Magnesium Salt Solution Using Day Before-Only Dosing Regimen in Adults.
NCT02273141 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Tolerability, Safety and Efficacy of an Adapted Gut Cleansing Solution in Routine Colon Cleansing Prior to Colonoscopies
NCT01251237 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Efficacy and Safety of Quiklean® and Klean-Prep With Dulcolax® for the Bowel Preparation Prior to Colonoscopy
NCT03992365 ·Status: COMPLETED ·Phase: PHASE3
-
The Use of Osmotic Laxatives Versus Macrogol for Bowel Preparation in Patients Undergoing Colonoscopy
NCT04225793 ·Status: UNKNOWN ·Phase: NA
-
F38-27: An Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects
NCT00857272 ·Status: COMPLETED ·Phase: PHASE4
-
Investigation of PicoPrep Versus HalfLytely for Bowel Preparation for Colonoscopy - Day Before PicoPrep
NCT01073943 ·Status: COMPLETED ·Phase: PHASE3
-
Application of Linaclotide Capsule in Bowel Preparation for Patients at High Risk of Inadequate Bowel Preparation
NCT05379491 ·Status: COMPLETED ·Phase: NA
-
Tolerability and Efficacy of Sodium Picosulfate/Magnesium Citrate Versus PEG/Ascorbic Acid in Ulcerative Colitis Patients
NCT03581149 ·Status: UNKNOWN ·Phase: PHASE4
-
Single Center Comparison of 4 FDA Approved, Commercially Available Bowel Purgatives for Colonoscopy
NCT02124447 ·Status: WITHDRAWN ·Phase: NA